These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36981781)

  • 41. Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study.
    Sun SF; Hsu CW; Sun HP; Hwang CW; Yang CL; Wang JL
    Neurorehabil Neural Repair; 2010 Jan; 24(1):34-41. PubMed ID: 19729582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
    Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
    Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.
    Rosales RL; Kong KH; Goh KJ; Kumthornthip W; Mok VC; Delgado-De Los Santos MM; Chua KS; Abdullah SJ; Zakine B; Maisonobe P; Magis A; Wong KS
    Neurorehabil Neural Repair; 2012 Sep; 26(7):812-21. PubMed ID: 22371239
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Local muscle injection of botulinum toxin type a synergistically improves the beneficial effects of repetitive transcranial magnetic stimulation and intensive occupational therapy in post-stroke patients with spastic upper limb hemiparesis.
    Yamada N; Kakuda W; Kondo T; Mitani S; Shimizu M; Abo M
    Eur Neurol; 2014; 72(5-6):290-8. PubMed ID: 25323412
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of upper limb spasticity after stroke: one-year safety and efficacy of botulinum toxin type A NT201.
    Fiore P; Santamato A; Ranieri M; Bellomo RG; Saggini R; Panza F; Megna G; Cristella G; Megna M
    Int J Immunopathol Pharmacol; 2012; 25(1 Suppl):57S-62S. PubMed ID: 22652163
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Impact of integrated upper limb spasticity management including repeat botulinum toxin type A (BoNT-A) injections on patient-centred goal attainment in real-life practice: results from the prospective, observational Upper Limb International Spasticity cohort study (ULIS-III) in a Russian subpopulation].
    Khat'kova SE; Baikova A; Maisonobe P; Khasanova DR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11):39-48. PubMed ID: 34932284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A; Micello MF; Panza F; Fortunato F; Baricich A; Cisari C; Pilotto A; Logroscino G; Fiore P; Ranieri M
    J Neurol Sci; 2014 Dec; 347(1-2):39-43. PubMed ID: 25263601
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Can the early use of botulinum toxin in post stroke spasticity reduce contracture development? A randomised controlled trial.
    Lindsay C; Ispoglou S; Helliwell B; Hicklin D; Sturman S; Pandyan A
    Clin Rehabil; 2021 Mar; 35(3):399-409. PubMed ID: 33040610
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of botulinum toxin in modifying spasticity to improve walking and quality of life in post-stroke lower limb spasticity - a randomized double-blind placebo controlled study.
    Datta Gupta A; Visvanathan R; Cameron I; Koblar SA; Howell S; Wilson D
    BMC Neurol; 2019 May; 19(1):96. PubMed ID: 31078139
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial.
    Nam HS; Park YG; Paik NJ; Oh BM; Chun MH; Yang HE; Kim DH; Yi Y; Seo HG; Kim KD; Chang MC; Ryu JH; Lee SU
    J Neurol Sci; 2015 Oct; 357(1-2):192-7. PubMed ID: 26233808
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Botulinum toxin type A injection, followed by home-based functional training for upper limb hemiparesis after stroke.
    Takekawa T; Kakuda W; Taguchi K; Ishikawa A; Sase Y; Abo M
    Int J Rehabil Res; 2012 Jun; 35(2):146-52. PubMed ID: 22453625
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exploratory Randomized Double-Blind Placebo-Controlled Trial of Botulinum Therapy on Grasp Release After Stroke (PrOMBiS).
    Wallace AC; Talelli P; Crook L; Austin D; Farrell R; Hoad D; O'Keeffe AG; Marsden JF; Fitzpatrick R; Greenwood R; Rothwell JC; Werring DJ
    Neurorehabil Neural Repair; 2020 Jan; 34(1):51-60. PubMed ID: 31747825
    [No Abstract]   [Full Text] [Related]  

  • 53. Influence of physician empathy on the outcome of botulinum toxin treatment for upper limb spasticity in patients with chronic stroke: A cohort study.
    Picelli A; Vallies G; Chemello E; Gavras A; Castellazzi P; Meschieri A; Serina A; Gandolfi M; Baricich A; Santamato A; Cisari C; Smania N
    J Rehabil Med; 2017 May; 49(5):410-415. PubMed ID: 28471469
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity.
    Demetrios M; Khan F; Turner-Stokes L; Brand C; McSweeney S
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009689. PubMed ID: 23740539
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long lasting benefits following the combination of static night upper extremity splinting with botulinum toxin A injections in cerebral palsy children.
    Kanellopoulos AD; Mavrogenis AF; Mitsiokapa EA; Panagopoulos D; Skouteli H; Vrettos SG; Tzanos G; Papagelopoulos PJ
    Eur J Phys Rehabil Med; 2009 Dec; 45(4):501-6. PubMed ID: 20032908
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the effects of modified constraint-induced movement therapy and intensive conventional therapy with a botulinum-a toxin injection on upper limb motor function recovery in patients with stroke.
    Nasb M; Li Z; S A Youssef A; Dayoub L; Chen H
    Libyan J Med; 2019 Dec; 14(1):1609304. PubMed ID: 31032717
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuronox versus BOTOX in the Treatment of Post-Stroke Upper Limb Spasticity: A Multicenter Randomized Controlled Trial.
    Seo HG; Paik NJ; Lee SU; Oh BM; Chun MH; Kwon BS; Bang MS
    PLoS One; 2015; 10(6):e0128633. PubMed ID: 26030192
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.
    Brashear A; Gordon MF; Elovic E; Kassicieh VD; Marciniak C; Do M; Lee CH; Jenkins S; Turkel C;
    N Engl J Med; 2002 Aug; 347(6):395-400. PubMed ID: 12167681
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity.
    Baguley IJ; Nott MT; Turner-Stokes L; De Graaff S; Katrak P; McCrory P; de Abadal M; Hughes A
    J Rehabil Med; 2011 Nov; 43(11):1032-7. PubMed ID: 22031350
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Short-term effect of local muscle vibration treatment versus sham therapy on upper limb in chronic post-stroke patients: a randomized controlled trial.
    Costantino C; Galuppo L; Romiti D
    Eur J Phys Rehabil Med; 2017 Feb; 53(1):32-40. PubMed ID: 27598342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.